Financial reports
10-Q
2023 Q3
Quarterly report
21 Nov 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
10-K/A
2022 FY
Annual report (amended)
19 Sep 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
22 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
Current reports
8-K
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp
31 Jan 24
8-K
Entry into a Material Definitive Agreement
24 Jan 24
8-K
Newcourt Acquisition Corp Announces Continuation
23 Jan 24
8-K
Other Events
22 Jan 24
8-K
Other Events
22 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
19 Jan 24
8-K
Corporate Presentation Proposed Business Combination with Newcourt Acquisition Corporation January 2024
16 Jan 24
8-K
Other Events
30 Nov 23
8-K
Psyence Group Announces Sec Effectiveness of F-4 for Proposed Business Combination Between Subsidiary and Nasdaq-listed Newcourt Acquisition Corp
15 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2 Nov 23
Registration and prospectus
15-12G
Securities registration termination
5 Feb 24
25-NSE
Exchange delisting
26 Jan 24
425
Business combination disclosure
23 Jan 24
425
Business combination disclosure
22 Jan 24
425
Business combination disclosure
22 Jan 24
425
Business combination disclosure
22 Jan 24
425
Business combination disclosure
17 Jan 24
425
Business combination disclosure
16 Jan 24
425
Business combination disclosure
30 Nov 23
425
Business combination disclosure
15 Nov 23
Proxies
DEF 14A
Definitive proxy
22 Jan 24
DEFA14A
Additional proxy soliciting materials
12 Jan 24
DEFA14A
Additional proxy soliciting materials
11 Jan 24
PRE 14A
Preliminary proxy
9 Jan 24
DEFM14A
Proxy related to merger
15 Nov 23
DEFA14A
Additional proxy soliciting materials
7 Jul 23
DEF 14A
Definitive proxy
23 Jun 23
PRE 14A
Preliminary proxy
9 Jun 23
DEFA14A
Additional proxy soliciting materials
30 Dec 22
DEF 14A
Definitive proxy
21 Dec 22
Other
UPLOAD
Letter from SEC
5 Oct 23
CORRESP
Correspondence with SEC
19 Sep 23
UPLOAD
Letter from SEC
5 Sep 23
UPLOAD
Letter from SEC
21 Dec 22
CORRESP
Correspondence with SEC
20 Dec 22
CORRESP
Correspondence with SEC
16 Dec 22
EFFECT
Notice of effectiveness
20 Oct 21
CERT
Certification of approval for exchange listing
19 Oct 21
CORRESP
Correspondence with SEC
15 Oct 21
CORRESP
Correspondence with SEC
15 Oct 21
Ownership
SC 13G/A
GLAZER CAPITAL, LLC
14 Feb 24
SC 13G/A
Saba Capital Management, L.P.
8 Feb 24
SC 13D/A
Newcourt SPAC Sponsor LLC
16 Jan 24
4
Marc Gregory Balkin
16 Jan 24
4
Change in insider ownership
17 Jul 23
3
de Vyver Jurgen Johannes van
22 Jun 23
3/A
Initial statement of insider ownership (amended)
8 Mar 23
4
Change in insider ownership
8 Mar 23
3
Initial statement of insider ownership
23 Feb 23
SC 13G/A
Polar Asset Management Partners Inc.
15 Feb 23